Relation between mean platelet volume and subclinical atherosclerosis in patients with metabolic syndrome [Metabolik sendromlu hastalarda ortalama trombosit hacminin subklinik ateroskleroz ile ilişkisi]

Basit Öğe Kaydı
dc.contributor.authorGülcan A.R.
dc.contributor.authorKarakaş M.S.
dc.contributor.authorAkdemir B.
dc.contributor.authorUçar M.
dc.contributor.authorAltekin R.E.
dc.contributor.authorYilmaz H.
dc.date.accessioned2019-08-01T13:38:39Z
dc.date.available2019-08-01T13:38:39Z
dc.date.issued2014
dc.departmentNiğde ÖHÜ
dc.description.abstractObjectives: Metabolic syndrome (MetS) is associated with increased cardiovascular morbidity and mortality. There is evidence of platelet activation in MetS. Mean platelet volume (MPV), a determinant of platelet activation, is a newly emerging risk factor for atherothrombosis. Therefore, we investigated the possible association between subclinical atherosclerosis, as evaluated by carotid intima-media thickness (CIMT) measurement and MPV, in MetS patients. Study design: Seventy-four patients with MetS were enrolled in the study. Patients were divided into two groups according to CIMT measurement: 35 patients with CIMT ?1.0 mm were in Group 1 and 39 patients with CIMT <1.0 mm were in Group 2. MPV was measured using an automated blood cell counter. Results: The MPV level was significantly higher in patients with CIMT ?1.0 mm than in patients with CIMT <1.0 mm (8.2±0.7 vs. 7.8±0.6 fl; p=0.01). In our study, we observed that platelet count was lower in KIMK ?1.0 mm group and this finding was also found to be statistically significant. Conclusion: The risk of atherosclerosis could be shown by following the MPV values in MetS patients. Therefore, our results suggest that MPV is an important marker for early detection of atherosclerotic risk in patients with MetS. © 2014 Türk Kardiyoloji Dernegi.
dc.identifier.doi10.5543/tkda.2014.50708
dc.identifier.endpage28
dc.identifier.issn1016-5169
dc.identifier.issue1
dc.identifier.pmid24481091
dc.identifier.startpage22
dc.identifier.urihttps://dx.doi.org/10.5543/tkda.2014.50708
dc.identifier.urihttps://hdl.handle.net/11480/761
dc.identifier.volume42
dc.indekslendigikaynakPubMed
dc.institutionauthor[0-Belirlenecek]
dc.language.isotr
dc.publisherTurkish Anaesthesiology and Intensive Care Society
dc.relation.ispartofTurk Kardiyoloji Dernegi Arsivi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAtherosclerosis
dc.subjectBlood platelets/pathology
dc.subjectMetabolic syndrome X
dc.subjectPlatelet activation
dc.subjectPlatelet count
dc.titleRelation between mean platelet volume and subclinical atherosclerosis in patients with metabolic syndrome [Metabolik sendromlu hastalarda ortalama trombosit hacminin subklinik ateroskleroz ile ilişkisi]
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu